Article
Lung-cancer chemoprevention by induction of synthetic lethality in mutant KRAS premalignant cells in vitro and in vivo.
Cancer prevention research (Philadelphia, Pa.) - 1 May 2011
Huang Shaoyi, Ren Xiaoyang, Wang Lai, Zhang Ling, Wu Xiangwei
Abstract excerpt
Lung cancer is the leading cause of cancer death in both men and women in the United States, with a low 5-year survival rate despite improved treatment strategies. These data underscore the great need for effective chemoprevention of this cancer. Mutations and activation of KRAS occur frequently in, and are thought to be a primary driver of the development of, non-small cell lung cancers (NSCLC) of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
